Catheter PrecisionVTAK

13F holders, Q4 2025 (December 31)
9holders +6
5new positions
0sold out
2famous investors
$1.83avg. 13F price*

At the end of Q4 2025, 9 institutions reported holding Catheter Precision Inc. (VTAK) in their 13F filings, up 6 from Q3 2025. 5 opened new positions and 0 sold out. The largest holders were Millennium Management ($64K), Vanguard Group Inc. ($29K) and Citadel Advisors ($23K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Catheter Precision Inc.
CUSIP
74933X708
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q3 2025: 3Q3 2025Q4 2025: 9Q4 2025Q1 2026: 12Q1 2026Q2 2026: 10Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions5$125K
Exits0$0

All 13F filers, Q3 2025 → Q4 2025: 68,356 shares bought, net +68,356 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 9 holders

Millennium Management 0.00% New 34,721 $64K
Vanguard Group Inc. 0.00% New 15,660 $29K
Citadel Advisors 0.00% New 12,771 $23K
Tower Research Capital LLC (TRC) 0.00% New 3,379 $6K
UBS Group AG 0.00% New 1,538 $3K
Bank of America Corp. 0.00% Add +2870.0% 297 $544
Purpose Unlimited Inc. 0.00% — 13 $23
Harbour Investments, Inc. 0.00% No change 8 $15
SBI Securities Co., Ltd. 0.00% No change 5 $9

"% of holder's portfolio" is VTAK's weight in each manager's 13F, not the share of Catheter Precision Inc. the manager owns.